Biltmore Family Office, LLC Novartis Ag Transaction History

Biltmore Family Office, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $590,330 - $667,778	-7,369 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $210,338 - $244,700	2,572 Added 53.62%	7,369 $603,000
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $132,719 - $160,531	-1,700 Reduced 26.17%	4,797 $453,000
Q2 2020 Aug 05, 2020	SELL	$80.93 - $91.1 $6,474 - $7,288	-80 Reduced 1.22%	6,497 $567,000
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $11,307 - $15,841	160 Added 2.49%	6,577 $542,000

Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $30,053 - $33,464	408 Added 6.79%	6,417 $551,000
Q2 2018 Jul 17, 2018	SELL	$64.91 - $73.36 $1,492 - $1,687	-23 Reduced 0.38%	6,009 $454,000
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $50,962 - $60,924	-724 Reduced 10.72%	6,032 $508,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $488,661 - $524,535	6,756	6,756 $567,000

1,343

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Biltmore Family Office, LLC with notifications on news.